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Background: Evidence is accruing to suggest that microbiota-gut-brain signalling plays a regulatory role in
cardiorespiratory physiology. Chronic intermittent hypoxia (CIH), modelling human sleep apnoea, affects gut
microbiota composition and elicits cardiorespiratory morbidity. We investigated if treatment with prebiotics
ameliorates cardiorespiratory dysfunction in CIH-exposed rats.
Methods: Adult male rats were exposed to CIH (96 cycles/day, 6.0% O2 at nadir) for 14 consecutive days with
and without prebiotic supplementation (fructo- and galacto-oligosaccharides) beginning two weeks prior to
gas exposures.
Findings: CIH increased apnoea index and caused hypertension. CIH exposure had modest effects on the gut
microbiota, decreasing the relative abundance of Lactobacilli species, but had no effect on microbial func-
tional characteristics. Faecal short-chain fatty acid (SCFA) concentrations, plasma and brainstem pro-inflam-
matory cytokine concentrations and brainstem neurochemistry were unaffected by exposure to CIH.
Prebiotic administration modulated gut microbiota composition and diversity, altering gut-metabolic
(GMMs) and gut-brain (GBMs) modules and increased faecal acetic and propionic acid concentrations, but
did not prevent adverse CIH-induced cardiorespiratory phenotypes.
Interpretation: CIH-induced cardiorespiratory dysfunction is not dependant upon changes in microbial functional
characteristics and decreased faecal SCFA concentrations. Prebiotic-related modulation of microbial function and
resultant increases in faecal SCFAs were not sufficient to prevent CIH-induced apnoea and hypertension in our
model. Our results do not exclude the potential for microbiota-gut-brain axis involvement in OSA-related cardio-
respiratory morbidity, but they demonstrate that in a relatively mild model of CIH, sufficient to evoke classic car-
diorespiratory dysfunction, such changes are not obligatory for the development of morbidity, but may become
relevant in the elaboration andmaintenance of cardiorespiratory morbidity with progressive disease.
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biome Ireland is funded by Science Foundation Ireland, through the Government’s National Development Plan.
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Research in context
Evidence before this study
Studies to date highlight a contributory role of perturbations to
microbiota-gut-brain axis signalling in the manifestation of
obstructive sleep apnoea (OSA)-induced cardiorespiratory dys-
function. There is a growing interest in developing strategies to
manipulate the microbiota as a potential therapeutic interven-
tion in the treatment of cardiorespiratory disease.
Added value of this study
Chronic intermittent hypoxia (CIH) exposure in rats, which
caused increased apnoea index and hypertension, had modest
effects on the gut microbiota. Faecal short-chain fatty acid
(SCFA) concentrations, pro-inflammatory cytokine concentra-
tions and brainstem neurochemistry were unaffected by expo-
sure to CIH. Prebiotic administration modulated gut microbiota
composition, diversity and function, but did not prevent
adverse CIH-induced cardiorespiratory phenotypes.
Implications of all the available evidence
We revealed for the first time using whole-metagenome shot-
gun sequencing that Lactobacilli species are decreased in CIH-
exposed rats, but gut microbial functional characteristics are
unaltered. Faecal SCFA concentrations were not altered by CIH
exposure. Prebiotics modulated gut-metabolic and gut-brain
modules and increased faecal SCFAs, but these changes were
not sufficient to prevent CIH-induced cardiorespiratory dys-
function in our model. Our results contribute to a growing
interest in the role of the microbiota-gut-brain axis in OSA-
related morbidities.
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Obstructive sleep apnoea (OSA), the most common form of sleep-
disordered breathing (SDB), is recognised as a major worldwide
health crisis with devastating consequences for integrative body sys-
tems [1]. OSA is characterised by repetitive collapse of the pharyngeal
airway during sleep, with episodic oxygen fluctuations culminating
in recurrent exposure to chronic intermittent hypoxia (CIH). It is now
apparent that exposure to CIH has adverse effects on the cardiorespi-
ratory control network and is recognised as a major driver of OSA-
related morbidities [2-8].
Studies have recurrently implicated the carotid bodies, the domi-
nant peripheral oxygen sensors, in the manifestation of CIH-induced
cardiorespiratory dysfunction [5, 6, 9-12]. However, exposure to CIH
elicits cardiorespiratory and autonomic disturbances in guinea-pigs
with hypoxia-insensitive carotid bodies [13, 14], revealing that sites
beyond the carotid bodies can contribute to the manifestation of CIH-
induced cardiorespiratory and autonomic disturbances. It is known
that CIH-induced plasticity also occurs at other key sites of the car-
diorespiratory control circuit, including the nucleus tractus solitarius
(NTS), pre-B€otzinger complex, ponto-medullary network and para-
ventricular nucleus of the hypothalamus [15-20]. More recently,
studies have described effects of CIH on other peripheral sites includ-
ing the gut microbiota [12, 14, 21-26].
The microbiota-gut-brain axis plays a critical regulatory role in
physiological systems [27]. Dysregulated microbiota-gut-brain axis
signalling affects homoeostatic neurocontrol networks manifesting
in pathophysiological behaviours and brain functions [28-30]. Recent
studies extend this concept to cardiorespiratory control [14, 31].There is considerable interest in the modulatory role of the gut
microbiota and gut microbiota metabolites, particularly short-chain
fatty acids (SCFAs), in cardiovascular and autonomic function [32-
35]. Proliferation of lactate-producing, as well as diminished buty-
rate- and acetate-producing taxa is evident in hypertensive models
[32, 34, 36, 37]. Hypertensive donor faeces transferred to normoten-
sive animals leads to the development of hypertension in recipient
animals [34, 37, 38]. Moreover, in a rat model of SDB, prebiotic
administration stimulates the expansion of beneficial commensal
microbiota augmenting several SCFA-producing taxa, restoring caecal
acetate concentrations and preventing the establishment of hyper-
tension [33]. Chronic acetate administration into the caecum of
OSA + high-fat diet (OSA+ HFD) rats prevents the development of
high blood pressure [33]. Additionally, butyrate treatment in
angiotensin-II-induced hypertensive mice as well as spontaneously
hypertensive rats prevented the establishment of hypertension
[32, 39].
In rat models, disruption of the gut microbiota using antibiotic
administration, faecal microbiota transfer or pre-natal stress results
in altered ventilatory responses to hypoxic and hypercapnic chemo-
stimulation [29, 31]. Respiratory frequency response to hypercapnic
chemostimulation correlated with altered bacterial genera in adult
rats with antecedent pre-natal stress [29]. Several genera, predomi-
nantly from the Firmicutes phylum correlated with brainstem neuro-
modulators crucial in the control of breathing [31]. Exposure to CIH
dysregulates cardiorespiratory control in guinea-pigs resulting in
aberrant phenotypes including altered autonomic control of heart
rate, decreased respiratory variability and prevalence of protective
sighs and brainstem noradrenaline concentrations, as well as dis-
turbed gut microbiota indicating that aberrant gut microbiota may at
least partly contribute to cardiorespiratory and autonomic malaise in
CIH-exposed guinea-pigs [14].
Collectively, these studies and others [25, 40] highlight a contribu-
tory role of perturbations to microbiota-gut-brain axis signalling in
the manifestation of OSA-induced cardiorespiratory dysfunction.
There is a growing interest in developing strategies to manipulate
the microbiota as a potential therapeutic intervention in the treat-
ment of cardiorespiratory disease. Rodent and human studies have
revealed that prebiotic administration has positive impacts on brain
neurochemistry and functions [30, 41-44]. Moreover, prebiotic feed-
ing prevented the development of hypertension in a rat model of
OSA [33]. Therefore, we assessed cardiorespiratory physiology and
gut microbiota composition and diversity in adult rats following
exposure to normoxia (Sham) or CIH. We hypothesised that there
would be evidence of cardiorespiratory and autonomic dysfunction
and altered gut microbiota in CIH-exposed rats. We examined the
effects of prebiotic fibre supplementation to test the hypothesis that
manipulation of the gut microbiota ameliorates or prevents the dele-
terious effects of exposure to CIH on cardiorespiratory physiology.
We performed whole-genome shotgun sequencing in an attempt to
identify microbial patterns that underscore cardiorespiratory
homoeostasis and dysfunction.2. Materials and methods
2.1. Ethical approval
Procedures on live animals were performed in accordance with
European directive 2010/63/EU under authorisation from the Gov-
ernment of Ireland Department of Health (B100/4498) and Health
Products Regulatory Authority (AE19130/P070). Ethical approval was
obtained from University College Cork (AEEC #2013/035; #2017/
023) and procedures were carried out in accordance with guidelines
laid down by University College Cork’s Animal Welfare Body.
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Eight- to ten-week old adult male Sprague Dawley rats (n = 72;
purchased from Envigo, UK) were housed as age-matched pairs in
standard rat cages. Rodents had ad libitum access to standard rat
chow and were housed under a 12-hr light: 12-hr dark cycle.
2.3. Prebiotic administration
Eight-week old rats (n = 24) were randomly allocated to receive
equal concentrations of prebiotic fibres in the drinking water (PREB;
7.5 g/L of galactooligossaccharides and fructooligosaccharides;
source: Healy group, Tallaght, Dublin, Ireland) with ad libitum access
for 4-weeks to promote the growth of beneficial host microbiota.
Concentrations and prebiotics (galactooligossaccharides and fructoo-
ligosaccharides) were chosen based on results from previous studies
[45-47]. After 2 weeks of PREB treatment, a subset of rats were
exposed to CIH (see Section 2.4) for the final 2 weeks creating two
groups: Sham+PREB (n = 12) and CIH+PREB (n = 12).
2.4. Chronic intermittent hypoxia rat model
Ten-week old rats (n = 48) were randomly assigned to one of two
groups, each receiving water (vehicle (VEH)): Sham+VEH (n = 24) and
CIH+VEH (n = 24). CIH exposed rats were placed in chambers wherein
ambient oxygen concentration was tightly regulated using a dynamic
oxygen/nitrogen controller (OxycyclerTM; Biospherix, New York, NY,
USA). CIH exposure was comprised of 96 cycles of 90 secs of exposure
to hypoxia (nadir, FiO2 = 0.06, balance N2) and 180 secs of exposure to
normoxia (FiO2 =0.21; balance N2), over 8 h during the light phase for
14 consecutive days. Animals were studied on the day subsequent to
the last day of CIH exposure. Concurrently, rats assigned to the Sham
group were exposed to room air (normoxia) in the same room with
similar environmental cues for the duration of the study.
2.5. Assessment of respiratory flow in rats during quiet rest
2.5.1. Whole-body plethysmography
During quiet rest, whole-body plethysmography (DSI, St. Paul,
Minnesota, USA) was used to record respiratory flow signals during
quiet rest. Animals were placed into custom plethysmograph cham-
bers (6011427001 PN, DSI) with a room air flow rate maintained
at 3l/min. Animals were allowed to acclimate for 3090 min to
encourage habituation to the new surroundings. Paired contempora-
neous observations were performed during light hours in Sham+VEH
(n = 12) versus CIH+VEH (n = 12) and subsequently Sham+PREB (n =
12) versus CIH+PREB (n = 12) using a pair of plethysmograph cham-
bers.
2.5.2. Metabolic measurements
O2 consumption (VO2) and CO2 production (VCO2) were measured
in rodents throughout the experimental protocol (O2 and CO2 analy-
ser; AD Instruments, Colorado Springs, CO, USA) as previously
described [14, 31, 48, 49].
2.5.3. Experimental protocol
Once the acclimation period was complete and animals were con-
firmed to be at quiet rest, baseline parameters were recorded during
a 1015 min steady-state normoxia period (FiO2 = 0.21; balance N2).
This was followed by a 10 min poikilocapnic hypoxia challenge
(FiO2=0.10; balance N2). Normoxia was subsequently restored in each
chamber to re-establish stable baseline breathing. Thereafter, a sec-
ond baseline period was recorded followed by a 10 min hypercapnia
challenge (FiCO2 = 0.05; balance O2). Subsequently, a third normoxic
baseline period was recorded. Rats were then exposed to a 10 min
hypoxic hypercapnic challenge (FiO2 = 0.10; FiCO2 =0.05, balance N2).2.5.4. Data analysis for whole-body plethysmography
Respiratory parameters including tidal volume (VT), respiratory
frequency (fR), minute ventilation (VI), expiratory time (Te) and inspi-
ratory time (Ti) were recorded on a breath-by-breath basis for analy-
sis (FinePointe software Buxco Research Systems, Wilmington, NC,
USA). Artefacts relating to animal movement and sniffing in respira-
tory flow recordings were omitted from analysis. A single baseline
period during normoxia was determined by averaging the three
baseline recording epochs to determine resting steady-state respira-
tory and metabolic parameters. Ventilatory and metabolic data were
averaged and reported for the final 5 min of acute poikilocapnic hyp-
oxia, hypercapnia and hypoxic hypercapnia allowing sufficient time
for gas mixing in the custom plethysmograph chambers. Data are
expressed as absolute change from baseline values. Respiratory flow
recordings were assessed for the occurrence of augmented breaths
(sighs) during normoxia, poikilocapnic hypoxia and hypercapnia, as
well as the frequency of apnoea events (post-sigh and spontaneous
apnoeas) during normoxia as previously described [50]. The criterion
for an apnoea was a pause in breathing greater than two consecutive
missed breaths. Apnoea data are expressed as apnoea index (apnoea
events per hour), combining post-sigh and spontaneous apnoeas. A
sigh was defined as an augmented breath, double the amplitude of
the average VT. The frequency and amplitude of sighs were deter-
mined. Poincare plots expressing breath-to-breath (BBn) versus sub-
sequent breath-to-breath interval (BBn+1) were extrapolated
allowing for determination of short- (SD1) and long-term (SD2)
respiratory timing variability during steady-state baseline breathing.
VT, VI, VT/Ti, VO2 and VCO2 were normalised per 100 g body mass.
2.6. Assessment of cardiorespiratory parameters under urethane
anaesthesia
2.6.1. Surgical protocol and cardiorespiratory measures
Following whole-body plethysmography, cardiorespiratory param-
eters were assessed in Sham+VEH, CIH+VEH, Sham+PREB and CIH
+PREB rats (n = 1112 per group) under urethane anaesthesia (1.5 g/
kg i.p.; 20% w/v) following isoflurane induction (5% by inhalation in
room air). Throughout the surgical and experimental protocol, the
depth of anaesthesia was carefully assessed by monitoring reflex
responses to tail/paw pinch and the corneal reflex. Supplemental doses
of anaesthetic were given as required. Rodents were placed in a supine
position on a homoeothermic blanket system (Harvard Apparatus, Hol-
liston, MA, USA) and a rectal temperature probe and heating pad used
to maintain core temperature at 37 °C. A mid-cervical tracheotomy
was performed, followed by intravenous (i.v.) cannulation of the right
jugular vein for infusion of supplemental anaesthetic and drugs. The
carotid (n = 22)/femoral artery (n = 1) was cannulated for the recording
of arterial blood pressure and the withdrawal of blood samples for
arterial blood gas, pH and electrolyte analysis (i-STAT; Abbott Labora-
tories Ltd). Using a foot clip, peripheral oxygen saturation (SpO2; Starr
Life Sciences, PA, USA) was determined and maintained above 95% via
a bias flow of supplemental O2 passing the tracheal cannula sourced
from a gas mixing system (GSM-3 Gas Mixer; CWE Inc.). A pneumo-
tachometer (Hans Rudolf) and a CO2 analyser (microCapStar End-Tidal
CO2 analyser; CWE Inc., USA) were connected to the tracheal cannula
to measure tracheal flow and end-tidal CO2 (ETCO2), respectively. Dia-
phragm electromyogram (EMG) activity was continuously measured
using a concentric needle electrode (26 G; Natus Manufacturing Ltd.,
Ireland). Signals were amplified (x5,000), filtered (band pass;
5005000 Hz) and integrated (50 ms time constant; Neurolog system,
Digitimer Ltd., UK). Data were digitised via a PowerLab-LabChart v7
(ADInstruments) data acquisition system.
2.6.2. Experimental protocol
An arterial blood sample was obtained from each animal follow-
ing a 30 min stabilisation period, after which, a minimum 10 min
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parameters (FiO2 = 0.250.40; balance N2). The rats were exposed to
a poikilocapnic hypoxia challenge (FiO2 = 0.12, balance N2) for 5 min,
followed by a recovery period. Animals were then exposed to a 5 min
hypoxic hypercapnic challenge (FiO2 = 0.12, FiCO2 = 0.05, balance N2).
Following a recovery period, sodium cyanide (NaCN; 200 mg/kg i.v.)
was administered to evoke carotid body dependant increases in ven-
tilation. After an adequate recovery period and removal of the pneu-
motachometer, a second arterial blood sample was taken. Next, the
serotonin type 3 (5-HT3) receptor agonist phenylbiguanide (PBG; 25
mg/kg i.v.) was administered to stimulate pulmonary vagal afferent
C-fibres [51, 52] eliciting the classic pulmonary chemoreflex. Succes-
sively, phenylephrine (50mg/kg i.v.), sodium nitroprusside (50mg/kg
i.v.), atenolol (2 mg/kg i.v.), propranolol (1 mg/kg i.v.) and hexame-
thonium (25 mg/kg i.v.) were administered to assess cardiovascular
responses to pharmacological manipulation with sufficient recovery
periods allowed between each pharmacological challenge. Animals
were euthanised by urethane (i.v) overdose. One animal (Sham
+PREB, n = 1) presented with uncharacteristically poor ventilatory
and cardiovascular responses throughout the experimental protocol;
this animal was excluded from data analysis. In all animals, blood
was collected, prepared in 3% Na2EDTA (disodium salt dehydrate)
and centrifuged. Plasma was snap frozen in liquid nitrogen for subse-
quent analysis of corticosterone and pro-inflammatory cytokine con-
centrations. Whole brains were removed, separated into pons and
medulla oblongata, frozen in isopentane at 80 °C and stored at 80
°C until subsequent analysis by high-performance liquid chromatog-
raphy. The lungs were removed and weighed and were allowed to air
dry at 37 °C for at least 48 hrs before being re-weighed to provide an
index of pulmonary oedema. The caecum was removed, weighed and
caecal contents were removed and snap frozen in liquid nitrogen
for whole-genome shotgun sequencing. Faeces were removed from
the colon for the assessment of SCFA concentrations by gas chroma-
tography. The heart was removed, and the right ventricle was sepa-
rated from the left ventricle + septum and each were weighed
separately.
2.6.3. Data analysis of cardiorespiratory parameters in anaesthetised
rats
Baseline parameters were averaged over 10 min of stable record-
ing and data are presented as absolute values. For cardiorespiratory
and EMG responses to poikilocapnic hypoxia and hypoxic hypercap-
nia the average of the last minute of recordings was determined and
data were compared with the 1 min pre-challenge baseline. Data for
drug challenges were averaged into 3 or 5 second bins and the peak
cardiorespiratory responses to NaCN, PBG, phenylephrine, sodium
nitroprusside, atenolol, propranolol and hexamethonium administra-
tion were determined and compared to the respective 1 min pre-
challenge baseline. Maximum apnoea and post-apnoea tachypnoea
in response to PBG are expressed as the duration of the apnoea or
tachypnoea period normalised in each trial to the average cycle dura-
tion determined during the 30 s pre-challenge baseline period. All
cardiorespiratory responses to chemostimulation and drug adminis-
tration are expressed as percent change from the preceding baseline
values.
2.7. Brainstem monoamine concentrations
2.7.1. High-performance liquid chromatography (HPLC) coupled to
electrochemical detection for the measurement of brainstem monoamine
concentrations
Pons (n = 1112/group) and medulla oblongata (n = 1112/
group) tissues were sonicated (Bandelin Sonopuls HD 2070) in 1 ml
of chilled mobile phase, spiked with 2 ng/20ml of a N-methyl 5-HT as
internal standard. Brainstem monoamine, precursor and metabolite
concentrations were measured as previously described [14, 31].Noradrenaline (NA), dopamine (DA), serotonin (5-HT), and mono-
amine metabolites and precursor, 5-hydroxyindoleacetic acid (5-
HIAA), homovanillic acid (HVA), 3,4-Dihydroxyphenylacetic acid
(DOPAC) and L-3,4 dihydroxyphenylalanine (L-DOPA) were identified
by their characteristic retention times and concentrations deter-
mined by comparison against standard injections run at regular inter-
vals during sample analysis.
2.7.2. Data analysis
Class-VP5 software was used to process chromatographs. Concen-
trations (ng/g) of monoamines, precursors and metabolites in each
sample were determined using analyte:internal standard peak
response ratios.
2.8. Plasma and brainstem pro-inflammatory cytokine concentrations
2.8.1. Brainstem tissue homogenisation and protein quantification
A separate cohort of rats (Sham, n = 12; CIH, n = 12) were euthan-
ised by pentobarbitone (i.v.) overdose and whole brains were
removed. The pons and medulla oblongata were separated from the
brain, frozen in isopentane at 80 °C and stored at 80 °C until sub-
sequent determination of brainstem cytokine concentrations. Pons
and medulla oblongata tissue (Sham, n = 12; CIH, n = 12) were
weighed and sonicated (1 ml per 100 mg of tissue) in radioimmuno-
precipitation assay (RIPA buffer) (10X RIPA, deionised H20, 200Mm
sodium fluoride, 100Mm, phenylmethylsulfonylfluoride (PMSF), 1X
protease inhibitor cocktail and 1X phosphate inhibitor cocktail). Sam-
ples were centrifuged at 10,000 g for 15 min at 4 °C, to pellet mem-
branes and nuclei. The protein concentration of each sample was
determined using a bicinchoninic acid (BCA) protein quantification
assay (Thermo Fisher Scientific) as per the manufacturer’s instruc-
tions, at a dilution of 1:10.
2.8.2. Multiplex assay for measurement of plasma and brainstem pro-
inflammatory cytokines
Concentrations of interleukin (IL)1b, IL-4, IL-5, IL-10, IL-13,
interferon (IFN)-g , keratinocytechemoattractant/growth-related
oncogene (KC/GRO) and tumour necrosis factor (TNF)-a were mea-
sured in plasma (all groups; n = 1112/group) as well as pons and
medulla oblongata (Sham and CIH only; n = 12 each group) superna-
tants by sandwich immunoassay methods using commercially avail-
able detection kits (V-Plex Pro-inflammatory Panel 2 (rat) kit; Meso
Scale Discovery, Gaithersburg, USA) as per the manufacturer’s
instructions. For pons and medulla oblongata tissues, 100 mg of pro-
tein sample was loaded per well as previously described [51]. Plates
were read using QuickPlex SQ 120 imager and computer (Meso Scale
Discovery).
2.9. Plasma corticosterone
Plasma samples were thawed and concentrations of corticoste-
rone were determined using commercially available enzyme-linked
immunosorbent assay kit according to the manufacturer’s instruc-
tions (ENZO Life Sciences, UK) using a spectrophotometer (Spectra-
Max M3, Molecular devices).
2.10. Microbiota composition and function
2.10.1. DNA extraction from caecal material
DNA was extracted from caecal material as previously described
[53].
2.10.2. Whole-metagenome shotgun sequencing
Whole-metagenome shotgun libraries were prepared in accor-
dance with the Nextera XT DNA Library Preparation Guide from Illu-
mina with the exception that the tagmentation time was increased to
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in the protocol, each sample was run on an Agilent bioanalyser high
sensitivity chip (Agilent) to determine the size range of the fragments
obtained. The concentration of the samples was also determined at
this point using a Qubit High Sensitivity Assay (Life-Sciences). Sam-
ples were then pooled equimolarly and the final concentration of the
pooled library was determined by quantitative PCR using the Kapa
Library Quantification kit for Illumina (Roche). The pooled library
was then sequenced on the Illumina NextSeq using the 2 £ 150 High
Output kit according to standard Illumina sequencing protocols.
2.10.3. Metagenomic bioinformatic analysis
Shotgun metagenomic sequence files (BCL, base calls) were con-
verted to fastq format using bcl2fastq version 2.19. Forward and
reverse fastq files were processed using KneadData version 0.7.2
from the Huttenhower bioBakery suite [54]. A reference library was
created to remove host DNA in Bowtie2 version 2.3.4 from the NCBI
rat genome (Rattus norgegicus, GCF 000,001,895.5). Quality filtering
was performed using the default setting (ex., phred=33) and trim-
ming with Trimmomatic version 0.381. Resulting high quality
paired-end reads for each sample were then concatenated in Knead-
Data. Kraken2 version 2.0.7-beta was used for taxonomic classifica-
tion with the standard database. Report files of taxonomic counts for
each sample were merged into a single count file using a custom R
script and ran in R version 3.5.2.
2.10.4. Functional annotation, gut-brain module and gut-metabolic
module analysis
Humann2 was used to generate a table of Kyoto encyclopaedia of
Genes and Genomes (KEGG) Orthologues. This table was aggregated
into gut-brain modules (GBMs) and gut-metabolic modules (GMMs),
pathways of functions performed by the gut microbiome that have
the potential to influence the host brain [55, 56], using the omixer-
rpmR library for R [57].
2.11. Faecal short-chain fatty acid concentrations
SCFA analysis and extraction were carried out by MS-Omics (Ved-
baek, Denmark) as follows. Faecal water was prepared by homogenis-
ing the faecal samples (approximately 100 mg) in ultrapure water (3
ml/mg). Samples were then vortexed for 2 min followed by centrifuga-
tion (5 min, 30,000 g, 5 °C). The supernatant was transferred to a centri-
fuge filter and the filtered samples were used for analysis. The filtrate
was acidified using hydrochloride acid, and deuterium labelled internal
standards where added. All samples were analysed in a randomized
order. Analysis was performed using a high polarity column (ZebronTM
ZB-FFAP, GC Cap. Column 30m x 0.25mm x 0.25mm) installed in a gas
chromatography (GC; 7890B, Agilent) coupled with a quadropole
detector (59977B, Agilent). The system was controlled by ChemStation
(Agilent). Raw datasets were converted to netCDF format using Chem-
station (Agilent), before the data was imported and processed inMatlab
R2014b (Mathworks, Inc.) using the PARADISe software [58]. Data are
expressed as absolute concentration in mM.
2.12. Statistical analysis
Data (except microbiota data) were assessed for outliers, nor-
mal distribution and equality of variances using box-plots, Sha-
piro-Wilk test and Levene’s test, respectfully. Parametric data
were statistically compared using independent samples t-test and
two-way ANOVA followed by Fisher’s least significant test for pair-
wise comparisons, where appropriate. Non-parametric data were
statistically compared using Mann-Whitney U test and Kruskal-
Wallis test followed by Mann-Whitney U test for pairwise compar-
isons, where appropriate. Statistical significance was assumed at
p<0.05. Bonferroni correction was applied to adjust for multiplecomparisons with the exception of microbiota data. Statistical sig-
nificance for multiple comparisons was accepted at p<0.05 divided
by the number of comparisons made.
As part of filtering, microbes prevalent in only 5% or fewer samples
were excluded. For differential abundance analysis, an additional
threshold of 0.5% abundance had to be reached in at least one sample to
be considered. When handling compositional data, the compositionally
appropriate centred-log ratio (clr) transformation was performed using
the ALDEx2 R library in preparation of statistical testing [59]. The
ALDEx2 library was also used to test for differentially abundant features,
using a pairwise implementation of the aldex.ttest() function to compare
multiple groups. Benjamini-Hochberg (BH) adjustment procedure was
applied with the false discovery rate (FDR) set at 10% to correct for mul-
tiple testing in the relative abundance microbiota data The 2D principal
component analysis (PCA) plot was constructed using the clr trans-
formed values computed using the ALDEx2 [60] library in R (version
3.6.0) with Rstudio (version 1.1.453), as is appropriate for compositional
data [61] using recommended parameters and 1000 permutations. Pair-
wise PERMANOVA was used to analyse the 2D PCA plot. Alpha diversity
indices were statistically analysed using non parametric Mann-Whitney
U test, followed by Bonferroni-Holm. For correlation analysis between
bacterial species and physiological parameters of interest, Hierarchical
All-against-All association testing (HAllA) [62] was used (version 0.8.7)
with Spearman correlation as correlation metric, medoid as clustering
method and q < 0.1 as threshold for significance. Microbiota data are
expressed as median (IQR). All other data are expressed as mean § SD
or displayed graphically as box and whisker plots (median, IQR and
minimum to maximum values). SPSS v25 was used for all other statisti-
cal analysis. GraphPad Software v6 (GraphPad Software, San Diego, CA,
USA) and R software environment were used to generate graphs. Adobe
illustrator CS5 (v15) was used to edit figures.
3. Results
3.1. Body and tissue weights
CIH exposure and prebiotic administration had a significant effect
on bodyweight (Diet*CIH, F (1, 43) = 5.426, p = 0.025, ƞ2=0.112, Table 1).
The combination of CIH+PREB decreased body weight gain compared
with CIH+VEH or Sham+PREB rats; Sham+PREB rats were also lighter
than Sham+VEH rats. CIH exposure had no effect on caecumweight but
as expected, prebiotic supplementation increased caecum weight. Dif-
ferences between groups in normalised cardiac ventricle weights relate
to changes in body weight (Supplementary Table 1).
3.2. Baseline ventilation and metabolism in rats during quiet rest
CIH exposure did not affect the majority of respiratory parameters
during normoxia. Prebiotic fibre supplementation increased baseline
VI, VT and VT/Ti in Sham+PREB and CIH+PREB compared with Sham
+VEH and CIH+VEH rats, respectively (Table 2), but the differences
related to body weight (Supplementary Table 1). CIH exposure had no
effect on VCO2 production; CIH+PREB rats had significantly increased
VCO2 production compared with CIH+VEH rats, but VCO2 production in
Sham+PREB rats was not different compared with Sham+VEH (Table 2).
CIH exposure had no effect on VI/VCO2 (breathing as a function of
metabolism), but prebiotic administration increased VI/VCO2, however
post hoc analysis revealed no difference between groups (Table 2). In
summary, CIH exposure and prebiotic administration had modest
effects on ventilation and metabolism during normoxia.
3.3. Respiratory timing variability, apnoeas and sighs during normoxia
in rats during quiet rest
Assessments of short-term (SD1) and long-term (SD2) respiratory
timing variability during normoxia did not reveal differences
Table 1
Body and tissue weights.












Body mass (g) 368 § 16 346 § 21 308 § 27 263 § 16 N/A Diet, p<0.0005;
CIH, p<0.0005;
Diet*CIH, p = 0.025
0.057 0.0005 <0.0005 <0.0005
RV (mg/100 g) 46 § 7.8 50§ 6 58 § 9.1 61§ 9.1 <0.0005 N/A 0.325 0.004 0.908 0.001
LV (mg/100 g) 235 § 24 232 § 19 238 § 22 236 § 22 N/A Diet, p = 0.280;
CIH, p = 0.810;
Diet*CIH, p = 0.603
   
LV+RV (mg/100 g) 278 § 18 282 § 15 299 § 25 297 § 29 Diet, p = 0.009;
CIH, p = 0.821;
Diet*CIH, p = 0.569
0.578 0.139 0.806 0.023
Caecum (g/100 g) 0.97 § 0.27 0.87 § 0.1 2.1 § 0.46 2.3 § 0.7 N/A Diet, p<0.0005;
CIH, p = 0.716;
Diet*CIH, p = 0.345
0.709 <0.0005 0.293 <0.0005
Oedema index
(% wet weight)
78 § 1 77§ 3 79 § 1 76§ 5 0.110 N/A    
BW, body weight; RV, right ventricle; LV, left ventricle; CIH, chronic intermittent hypoxia; PREB, prebiotic; VEH, vehicle. Data are shown as mean § SD and were statistically
compared using two-way ANOVA, followed by Fisher’s least significant difference (LSD) post hoc where appropriate, or non-parametric Kruskal-Wallis test, followed by Mann-
Whitney U test, where appropriate. Statistical significance for multiple comparisons was accepted at p<0.05 divided by the number of comparisons made, which was four i.e.
p<0.0125. p-values shown in bold highlight significant differences.
6 K.M. O’Connor et al. / EBioMedicine 59 (2020) 102968between groups (p>0.05; Fig. 1a-f). Apnoea index was significantly
increased by CIH exposure (X2(3) = 9.284, p = 0.026, Fig. 1j), a conse-
quence of alterations in spontaneous apnoea events; no statistically
significant differences were evident in post-sigh apnoea events
(Table 2). Post hoc analysis revealed that apnoea index was increased
in CIH+PREB compared with Sham+PREB rats (p = 0.008; Fig. 1j). The
frequency of sighs was not affected by CIH exposure or prebiotic
administration (p>0.05; Fig. 1k). Sham+PREB had elevated sigh
amplitude compared with Sham+VEH rats (Table 2). The major find-
ing was that CIH exposure increased apnoea index during quietTable 2
Baseline ventilation, apnoea, sigh and metabolism in rats during quiet rest.
Sham+VEH CIH+VEH Sham+PREB CIH+PREB p-value
(Kruskal-W
fR (brpm) 82 § 8 78 § 9 83§ 9 81§ 7 N/A
VI (ml/min/ 100 g) 53 § 9 54 § 6 63§ 9 71§ 6 <0.0005
VT (ml/100 g) 0.7 § 0.1 0.7 § 0.1 0.8 § 0.1 0.9 § 0.1 <0.0005
VT/Ti (ml/s/ 100 g) 2.8 § 0.6 2.6 § 0.4 3.1 § 0.5 3.4 § 0.3 N/A
Ti (ms) 254 § 26 277 § 21 260 § 28 268 § 21 N/A
Te (ms) 516 § 74 520 § 119 515 § 71 501 § 54 N/A
VO2 (ml/min/ 100 g) 2.7 § 0.7 2.4 § 0.8 3.1 § 1.1 3.3 § 1.1 N/A
VCO2 (ml/ min/100 g) 1.9 § 0.3 1.9 § 0.2 2.0 § 0.3 2.1 § 0.3 0.046
VI/VCO2 28 § 3 29 § 4 31§ 5 34§ 5 N/A
Post sigh apnoea (events
per hr)
12 § 6 19 § 13 9 § 5 16§ 9 0.083
Spontaneous apnoea
(events per hr)
3.3 § 5.0 5.5 § 6.8 3.6 § 5.2 10.0 § 7.5 0.044
Sigh amplitude
(ml/100 g)
0.8 § 0.2 1.2 § 0.4 1.2 § 0.2 1.4 § 0.2 <0.0005
fR, respiratory frequency (brpm, breaths per minute); Vi, minute ventilation; VT, tidal volum
consumption; VCO2, carbon dioxide production; VI/VCO2, ventilatory equivalent; CIH, chr
SD and were statistically compared using two-way ANOVA, followed by Fisher’s least signi
test, followed by Mann-Whitney U test, where appropriate. Statistical significance for m
made, which was four i.e. p<0.0125. p-values shown in bold highlight significant differencbreathing at rest (normoxia) and prebiotic administration did not
prevent this aberrant phenotype.
3.4. Ventilatory and metabolic responsiveness to chemostimulation in
rats during quiet rest
3.4.1. Ventilatory and metabolic responsiveness to hypoxic
chemostimulation
No significant differences were evident in CIH+VEH compared











Diet, p = 0.346;
CIH, p = 0.310;
Diet*CIH, p = 0.731
   
N/A 0.498 <0.0005 0.038 0.009
N/A 0.356 0.001 0.028 0.009
Diet, p<0.0005;
CIH, p = 0.833;
Diet*CIH, p = 0.113
0.331 <0.0005 0.198 0.093
Diet, p = 0.794;
CIH, p = 0.032;
Diet*CIH, p = 0.307
0.028 0.370 0.402 0.584
Diet, p = 0.688;
CIH, p = 0.825;
Diet*CIH, p = 0.706
   
Diet, p = 0.019;
CIH, p = 0.815;
Diet*CIH, p = 0.420
0.467 0.028 0.681 0.251
N/A 0.758 0.012 0.525 0.166
Diet, p = 0.003;
CIH, p = 0.107;
Diet*CIH, p = 0.603
0.073 0.128 0.015 0.438
N/A    
N/A 0.374 0.067 0.022 0.596
N/A 0.023 0.176 0.05 <0.0005
e; VT/Ti, mean inspiratory flow; Ti, inspiratory time; Te, expiratory time; VO2, oxygen
onic intermittent hypoxia; PREB, prebiotic; VEH, vehicle. Data are shown as mean §
ficant difference (LSD) post hocwhere appropriate, or non-parametric Kruskal-Wallis
ultiple comparisons was accepted at p<0.05 divided by the number of comparisons
es.
Fig. 1. CIH increases apnoea index
Poincare plots of breath-to-breath (BBn) and subsequent breath-to-breath (BBn + 1) interval of expiratory duration (Te; a) and total breath duration (Ttot; b) for Sham+VEH, CIH
+VEH, Sham+PREB and CIH+PREB. Group data for Te short-term variability (SD1; c) and long-term variability (SD2; d) and Ttot SD1 (e) and SD2 (f) in Sham+VEH, CIH+VEH, Sham
+PREB and CIH+PREB rats during normoxia. Representative respiratory flow traces (downward deflections represent inspiration) illustrating a spontaneous sigh followed by an
apnoea (g), a spontaneous apnoea (h) and a spontaneous sigh (i). Group data of apnoea index (j) and sigh frequency (k). CIH, chronic intermittent hypoxia; PREB, prebiotic; VEH,
vehicle. Groups (c-f, j, k) are expressed as box and whisker plots (median, IQR and minimum to maximum values); n = 1112. Groups were statistically compared using two-way
ANOVA, followed by Fisher’s least significant difference (LSD) post hoc where appropriate, or non-parametric Kruskal-Wallis test, followed by Mann-Whitney U test, where appro-
priate. Apnoea index was significantly affected by CIH exposure (p = 0.026; Fig. 1j). Assessments of respiratory timing variability and frequency of sighs were not different between
groups (p>0.05; Fig. 1a-f, 1k). # p = 0.008, CIH+PREB versus Sham+PREB.
K.M. O’Connor et al. / EBioMedicine 59 (2020) 102968 7increased Ti and Te compared with Sham+PREB rats (Table 3). Ti was
decreased in Sham+PREB compared with Sham+VEH rats (Table 3).
Sigh frequency and amplitude were not different in CIH+VEH com-
pared with Sham+VEH rats, but CIH+PREB rats had less frequent butlarger sighs compared with CIH+VEH rats. Sigh frequency was
reduced in CIH+PREB compared with Sham+PREB rats (Table 3). The
major observation was that prebiotic administration reduced the fre-
quency of sighs during hypoxia in CIH-exposed rats.
Table 3
Ventilatory and metabolic responsiveness to chemostimulation in rats during quiet rest.













D fR (brpm) 58 § 21 46 § 18 64 § 12 37 § 13 N/A Diet, p = 0.834;
CIH, p<0.0005;
Diet*CIH, p = 0.125
0.082 0.221 <0.0005 0.338
D VI (ml/min/100 g) 46 § 16 38 § 10 50 § 12 34 § 14 N/A Diet, p = 0.935;
CIH, p = 0.003;
Diet*CIH, p = 0.344
0.140 0.544 0.006 0.462
D VT (ml/100 g) 0.09 § 0.10 0.10 § 0.08 0.03 § 0.07 0.08 § 0.10 N/A Diet, p = 0.093;
CIH, p = 0.149;
Diet*CIH, p = 0.584
   
D VT/Ti (ml/s/100 g) 1.6 § 0.6 1.6 § 0.6 2.4 § 0.8 1.3 § 1 N/A Diet, p = 0.244;
CIH, p = 0.021;
Diet*CIH, p = 0.022
0.993 0.406 0.001 0.015
D Ti (ms) 79 § 36 81 § 27 108 § 27 65 § 24 0.005 N/A 0.786 0.295 0.001 0.008
D Te (ms) 228 § 90 170 § 106 230 § 54 125 § 51 N/A Diet, p = 0.365;
CIH, p = 0.001;
Diet*CIH, p = 0.298
0.085 0.176 0.002 0.921
D VO2 (ml/min/100 g) 0.7 § 0.7 0.4 § 1 1.3 § 1 1.5 § 1 N/A Diet, p = 0.003;
CIH, p = 0.858;
Diet*CIH, p = 0.480
0.536 0.011 0.705 0.095
D VCO2 (ml/min/100 g) 0.3 § 0.2 0.3 § 0.3 0.3 § 0.4 0.2 § 0.2 0.412 N/A    
D VI/VCO2 19 § 8 14 § 7 18 § 8 12 § 7 N/A Diet, p = 0.487;
CIH, p = 0.016;
Diet*CIH, p = 0.747
0.132 0.477 0.048 0.789
Sigh frequency (events per hr) 132 § 46 155 § 40 145 § 29 112 § 19 0.008 N/A 0.293 0.002 0.009 0.706
Sigh amplitude (ml/100g) 1.0 § 0.14 1.1 § 0.2 1.2 § 0.23 1.4 § 0.3 0.001 N/A 0.538 0.001 0.083 0.033
Hypercapnia
D fR (brpm) 60 § 21 49 § 17 57 § 18 50 § 21 N/A Diet, p = 0.908;
Exposure, p = 0.129;
Diet*Exposure, p = 0.689
   
D VI(ml/min/100 g) 55 § 18 55 § 16 85 § 29 73 § 24 N/A Diet, p = 0.001;
Exposure, p = 0.385;
Diet*Exposure, p = 0.380
0.994 0.064 0.214 0.002
D VT (ml/100 g) 0.18 § 0.18 0.2 § 0.1 0.23 § 0.1 0.3 § 0.1 0.019 N/A 0.268 0.056 0.729 0.021
D VT/Ti (ml/s/100 g) 1.4 § 0.7 1.6 § 0.7 2.8 § 1.1 2.5 § 0.7 N/A Diet, p<0.0005;
Exposure, p = 0.979;
Diet*Exposure, p = 0.327
0.480 0.01 0.494 <0.0005
D Ti (ms) 53 § 28 59 § 19 72 § 27 67 § 24 0.307 N/A    
D Te (ms) 304 § 109 232 § 89 223 § 67 190 § 112 0.081 N/A    
D VCO2 (ml/min/100 g) 0.4 § 0.7 0.2 § 0.6 0.7 § 0.6 0.3 § 0.9 0.213 N/A    
D VI/VCO2 27 § 16 41 § 14 28 § 19 41 § 33 0.150 N/A    
Sigh frequency (events per hr) 10 § 5 17 § 6 23 § 21 20 § 6 0.001 N/A 0.009 0.333 0.333 0.001
Sigh amplitude (ml/100 g) 1.1 § 0.3 1.5 § 0.3 1.6 § 0.3 1.4 § 0.2 0.017 N/A 0.031 0.389 0.389 0.006
Hypoxic hypercapnia
D fR (brpm) 58 § 10 50 § 16 65 § 18 56 § 11 N/A Diet, p = 0.157;
Exposure, p = 0.062;
Diet*Exposure, p = 0.790
   
D VI (ml/min/100 g) 76 § 20 69 § 15 110 § 20 95 § 23 N/A Diet, p<0.0005;
Exposure, p = 0.090;
Diet*Exposure, p = 0.562
0.446 0.006 0.088 <0.0005
D VT (ml/100 g) 0.3 § 0.2 0.3 § 0.1 0.4 § 0.2 0.4 § 0.2 0.030 N/A 0.683 0.286 0.094 0.010
D VT/Ti (ml/s/100 g) 2.0 § 0.9 2.0 § 0.7 3.4 § 0.8 2.8 § 1.0 N/A Diet, p<0.0005;
Exposure, p = 0.465;
Diet*Exposure, p = 0.204
0.713 0.070 0.135 0.001
D Ti (ms) 57 § 33 73 § 17 76 § 36 74 § 22 N/A Diet, p = 0.252;
Exposure, p = 0.412;
Diet*Exposure, p = 0.328
   
D Te (ms) 291 § 194 234 § 112 301 § 96 271 § 54 0.450 N/A    
D VCO2 (ml/min/100 g) 0.3 § 0.4 0.3 § 0.4 0.2 § 0.4 0.1 § 0.6 N/A Diet, p = 0.039;
Exposure, p = 0.304;
Diet*Exposure, p = 0.322
0.980 0.435 0.132 0.030
D VI/VCO2 62 § 23 55 2 § 5 55 § 21 53 § 26 N/A Diet, p = 0.573;
`Exposure, p = 0.586;
Diet*Exposure, p = 0.762
   
fR, respiratory frequency (brpm, breaths per minute); VI, minute ventilation; VT, tidal volume; VT/Ti, mean inspiratory flow; Ti, inspiratory time; Te, expiratory time; VO2, oxygen consumption; VCO2, car-
bon dioxide production; VI/VCO2, ventilatory equivalent; CIH, chronic intermittent hypoxia; PREB, prebiotic; VEH, vehicle. Data are shown as mean § SD and were statistically compared using two-way
ANOVA, followed by Fisher’s least significant difference (LSD) post hocwhere appropriate, or non-parametric Kruskal-Wallis test, followed by Mann-Whitney U test,where appropriate. Statistical signif-
icance for multiple comparisons was accepted at p<0.05 divided by the number of comparisons made, which was four i.e. p<0.0125. p-values shown in bold highlight significant differences.
8 K.M. O’Connor et al. / EBioMedicine 59 (2020) 1029683.4.2. Ventilatory and metabolic responsiveness to hypercapnic
chemostimulation
CIH exposure elevated sigh frequency during hypercapnia, as such
CIH+VEH rats had increased generation of sigh compared with Sham
+VEH rats. Other respiratory and metabolic parameters were not dif-
ferent in CIH+VEH compared with Sham+VEH rats in response to
hypercapnia (Table 3). Prebiotic administration in CIH-exposed rats
elevated VT/Ti compared with CIH+VEH rats. Interestingly, Sham
+PREB rats had elevated ventilation (VI) and increased drive to
breathe (VT/Ti) in response to hypercapnia compared with Sham
+VEH rats, with no change in VI/VCO2 (Table 3). Furthermore, Sham+PREB rats had augmented sigh frequency and amplitude compared
with Sham+VEH rats. There was no difference between CIH+PREB
and Sham+PREB rats (Table 3). The major finding was that prebiotic
fibre supplementation increased sigh frequency and the ventilatory
response to hypercapnia.
3.4.3. Ventilatory and metabolic responsiveness to hypoxic hypercapnic
chemostimulation
No significant differences were evident in CIH+VEH compared with
Sham+VEH rats. CIH+PREB rats had elevated VI compared with CIH
+VEH rats. Sham+PREB rats had an elevated ventilatory response to
Table 4
Baseline ventilation, blood gases and cardiovascular parameters in anaesthetised rats.












fR (brpm) 99 § 11 99 § 11 98 § 10 93 § 5 N/A Diet, p = 0.448;
CIH, p = 0.376;
Diet*CIH, p = 0.397
   
VI (ml/ min/ 100 g) 24 § 5 21 § 3 25 § 3 27 § 3 N/A Diet, p = 0.003;
CIH, p = 0.642;
Diet*CIH, p = 0.088
0.111 0.001 0.387 0.339
VT (ml/ 100 g) 0.25 § 0.05 0.22 § 0.03 0.26 § 0.02 0.29 § 0.03 N/A Diet, p<0.0005;
CIH, p = 0.998;
Diet*CIH, p = 0.019
0.081 <0.0005 0.103 0.306
ETCO2 5 § 1.6 6 § 0.5 5.7 § 0.6 6 § 0.9 N/A Diet, p = 0.274;
CIH, p = 0.448;
Diet*CIH, p = 0.316
   
pH 7.37 § 0.04 7.33 § 0.02 7.34 § 0.02 7.34 § 0.03 N/A Diet, p = 0.427;
CIH, p = 0.049;
Diet*CIH, p = 0.211
0.023 0.738 0.598 0.155
PaCO2 (mmHg) 46 § 6.4 51 § 3.7 51 § 4.4 49 § 4.9 N/A Diet, p = 0.394;
CIH, p = 0.278;
Diet*CIH, p = 0.049
0.03 0.406 0.518 0.050
PaO2 (mmHg) 97 § 3.8 99 § 6.9 97 § 13 98 § 6.2 N/A Diet, p = 0.416;
CIH, p = 0.863;
Diet*CIH, p = 0.822
   
Haematocrit (%) 49 § 2 49 § 2.8 45 § 2.8 42 § 13 0.004 N/A 0.975 0.035 0.947 0.004
[Hb] (g/dl) 16.8 § 0.7 16.8 § 1.0 15.4 § 1.0 15.7 § 1.3 N/A Diet, p<0.0005;
CIH, p = 0.696;
Diet*CIH, p = 0.580
0.907 0.013 0.510 0.002
fR, respiratory frequency (brpm, breaths per minute); VI, minute ventilation; VT, tidal volume; ETCO2, end-tidal carbon dioxide production; Pco2, partial pressure of arterial carbon dioxide; Pao2, partial pres-
sure of arterial oxygen; [Hb], haemoglobin concentration; CIH, chronic intermittent hypoxia; PREB, prebiotic; VEH, vehicle. Data are shown as mean § SD and were statistically compared using two-way
ANOVA, followed by Fisher’s least significant difference (LSD) post hoc where appropriate, or non-parametric Kruskal-Wallis test, followed by Mann-Whitney U test, where appropriate. Statistical signifi-
cance for multiple comparisons was accepted at p<0.05 divided by the number of comparisons made, which was four i.e. p<0.0125. p-values shown in bold highlight significant differences.
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increased VI, VT and VT/TI; VI/VCO2 was not different between groups
(Table 3). Furthermore, there was no apparent difference between
Sham+PREB and CIH+PREB rats. The major observation was that prebi-
otic administration elevated the ventilatory response to hypoxic
hypercapnia.
3.5. Baseline cardiorespiratory and blood gas parameters in
anaesthetised rats
CIH exposure had no effect on respiration in the anaesthetised rat
during baseline conditions (Table 4). VI and VT were increased in
PREB+CIH rats compared with CIH-exposed rats (Table 4). CIH expo-
sure significantly increased diastolic blood pressure (DBP) (CIH; F
(1,41) = 16.321, p<0.0005, ƞ2=0.285, Fig. 2b). As a consequence, mean
arterial blood pressure (MAP) was elevated (CIH; F (1, 41) = 17.485,
p<0.005, ƞ2=0.299). Post hoc analysis revealed CIH+VEH had elevated
blood pressure compared with Sham+VEH rats (DBP, p = 0.006,
Fig. 2b; MAP, p = 0.004, Fig. 2a). DBP was not restored by prebiotic
administration as CIH+PREB had elevated DBP compared with CIH
+VEH rats (p = 0.007, Fig. 2b). There was no statistical difference evi-
dent in MAP between CIH+PREB compared with CIH+VEH (p>0.05,
Fig. 2a), and MAP was elevated in CIH+PREB compared with Sham
+PREB rats (p = 0.006; Fig. 2a). CIH exposure or prebiotic administra-
tion had no effect on systolic blood pressure or heart rate (p>0.05,
Fig. 2c, 2d). CIH exposure had no effect on haematocrit and haemo-
globin concentrations; Sham+PREB had reduced concentrations com-
pared with Sham+VEH (Table 4).
CIH exposure increased the low-frequency band (LF) (CIH; nu, F
(1, 40) = 6.170, p = 0.017, ƞ2=0.134, Fig. 2f;%, F (1, 40) = 6.723, p =
0.013, ƞ2=0.144, Table 5) and decreased the high-frequency band
(HF; nm) (CIH, F (1, 40) = 1.159, p = 0.014, ƞ2=0.142, Table 5) ele-
vating the LF: HF ratio (CIH, F (1, 40) = 7.748, p = 0.008, ƞ2=0.162,
Fig. 2e) during steady-state baseline recordings, indicating sympa-
thetic dominance. LF:HF was increased in CIH+VEH compared with
Sham+VEH rats (p = 0.059, Fig. 2e). There was no difference in CIH
+PREB compared with CIH+VEH rats, however CIH+PREB rats had
elevated LF:HF ratio compared with Sham+PREB rats (p = 0.053,
Fig. 2e). After adjusting for multiple comparisons these changeswere not statistically significant (Table 5). Other heart rate vari-
ability parameters were not different between groups (Table 5).
The major finding was that CIH exposure caused hypertension and
cardiac autonomic imbalance, which were not alleviated by prebi-
otic supplementation.
3.6. Cardiorespiratory responses to 5-HT3 receptor agonism evoking the
cardiopulmonary reflex
Stimulation of 5-HT3 receptors expressed on pulmonary vagal
afferent nerve fibres, using PBG, evoked the integrated cardiopulmo-
nary reflex. CIH exposure had no effect on hypotension, bradycardia,
apnoea or post-apnoea induced tachypnoea associated with the pul-
monary chemoreflex (Fig. 3b-e). Prebiotic supplementation altered
apnoea duration (Diet, F (1, 41) = 4.950, p = 0.032, ƞ2=0.108, Fig. 3b),
however, post hoc analysis revealed no differences between groups.
There was no significant difference between groups in all other
parameters (Fig. 3c-e). The major finding was that pulmonary chemo-
reflex responses to vagal afferent stimulation were unaffected by CIH
exposure.
3.7. Cardiovascular responses to pharmacological blockade of
sympathetic activity in anaesthetised rats
The blood pressure response to b1 adrenoceptor antagonism
(atenolol) was significantly increased by exposure (X2(3) = 9.347, p =
0.025, Table 6). CIH+VEH was not different compared with Sham
+VEH rats. There was a greater depressor response in CIH+PREB com-
pared with Sham+PREB rats; the associated bradycardia was similar
between all groups (Table 6). Intravenous infusion of the non-selec-
tive b-adrenoceptor blocker (propranolol), and sympathetic ganglion
blocker (hexamethonium) evoked similar bradycardia and hypoten-
sive responses across all groups (Table 6).
3.8. Pons and medulla oblongata neurochemistry
Comparison of L-DOPA and DOPAC concentrations in the pons, as
well as DOPAC/DA, HVA, HVA/DA, 5-HT and 5-HIAA concentrations in
the medulla oblongata revealed group differences (p<0.05; Fig. 4a, 4c-
Fig. 2. CIH causes hypertension and cardiac autonomic imbalance
Group data for MAP (a), DBP (b), SBP (C), heart rate (D), LF: HF (e) and LF (f) for Sham+VEH, CIH+VEH, Sham+PREB and CIH+PREB. MAP, mean arterial blood pressure; DBP, dia-
stolic blood pressure; SBP, systolic blood pressure; LF, low-frequency band; HF, high frequency band; CIH, chronic intermittent hypoxia; PREB, prebiotic; VEH, vehicle. Groups (a-f)
are expressed as box and whisker plots (median, IQR and minimum to maximum values); n = 1012 for all groups. Groups were statistically compared using two-way ANOVA, fol-
lowed by Fisher’s least significant difference (LSD) post hoc where appropriate, or non-parametric Kruskal-Wallis test, followed by Mann-Whitney U test, where appropriate. CIH
significantly affected MAP, DBP, LF: HF and LF (p<0.005, p<0.0005, p = 0.008 and p = 0.017, respectively; Fig. 2a, 2b, 2e, 2f). There was no change in SBP or HR (p>0.05, Fig. 2c, 2d).*
p = 0.004, CIH+VEH versus Sham+VEH; # p<0.01, CIH+PREB versus Sham+PREB.
Table 5
Heart rate variability in the urethane anaesthetised rats.












Total Power (ms2) 16 § 28 10 § 11 4 § 3 13 § 15 0.653 N/A    
HF (nm) 78 § 11 71 § 10 84 § 7 73 § 10 N/A Diet, p = 0.288;
CIH, p = 0.014;
Diet*CIH, p = 0.662
0.138 0.648 0.039 0.301
VLF (ms2) 0.4 § 0.3 1.0 § 1.7 0.4 § 0.2 0.3 § 0.5 0.163 N/A    
LF (ms2) 0.3 § 0.5 0.4 § 0.5 0.1 § 0.1 0.5 § 0.7 0.214 N/A    
HF (ms2) 12 § 20 6 § 7 3 § 2 9 § 12 0.590 N/A    
VFL (%) 15 § 14 24 § 26 16 § 11 9 § 11 0.251 N/A    
LF (%) 4 § 2 5 § 3 4 § 1 6 § 4 N/A Diet, p = 0.658;
CIH, p = 0.013;
Diet*CIH, p = 0.619
0.146 0.497 0.035 0.970
HF (%) 66 § 15 53 § 15 70 § 11 67 § 11 0.109 N/A    
Average RRI (ms) 153 § 18 152 § 9 155 § 14 144 § 14 N/A Diet, p = 0.445;
CIH, p = 0.189;
Diet*CIH, p = 0.238
   
Median RRI (ms) 153 § 19 152 § 10 155 § 14 144 § 14 N/A Diet, p = 0.460;
CIH, p = 0.199;
Diet*CIH, p = 0.272
   
SDRR (ms) 3.3 § 2.5 3 § 2 2 § 0.5 3.6 § 2.3 0.626 N/A    
CVRR 0.02 § 0.02 0.02 § 0.01 0.01 § 0.003 0.03 § 0.02 0.373 N/A    
SD Rate (bpm) 8.2 § 5.8 7.8 § 5.2 5.2 § 1.5 11 § 8.4 0.380 N/A    
SDSD (ms) 4.5 4.7 4.1 § 3.8 2.6 § 1.2 5.5 § 4.2 0.586 N/A    
RMSSD (ms) 4.5 § 4.8 4.1 § 3.8 2.6 § 1.2 5.5 § 4.2 0.586 N/A    
SD1 (ms) 3.2 § 3.3 2.9 § 2.7 1.8 § 0.8 3.9 § 2.9 0.586 N/A    
SD2 (ms) 3.1 § 1.9 2.8 § 1.5 2.2 § 0.5 3.2 § 1.6 N/A Diet, p = 0.489;
CIH, p = 0.373;
Diet*CIH, p = 0.131
   
VLF, very low frequency; LF, low frequency; HF, high frequency; RRI, R-R interval; SDRR, standard deviation of R-R interval; CVRR, coefficient of variance of R-R intervals; SD rate, standard deviation of heart
rate; SDSD, standard deviation of successive R-R intervals; RMSSD, root mean square of successive R-R interval differences; SD1, short term variability; SD2, long-term variability; CIH, chronic intermittent
hypoxia; PREB, prebiotic; VEH, vehicle. Data are shown as mean§ SD and were statistically compared using two-way ANOVA, followed by Fisher’s least significant difference (LSD) post hocwhere appropri-
ate, or non-parametric Kruskal-Wallis test, followed by Mann-Whitney U test, where appropriate. Statistical significance for multiple comparisons was accepted at p<0.05 divided by the number of com-
parisons made, which was four i.e. p<0.0125. p-values shown in bold highlight significant differences.
10 K.M. O’Connor et al. / EBioMedicine 59 (2020) 102968f, 4h, 4i). However, post hoc analysis revealed that monoamine, mono-
amine metabolites and precursors were not different in CIH+VEH
compared with Sham+VEH rats in the pons or medulla oblongata(Fig. 4a-j). Pontine L-DOPA (p = 0.020) and medulla oblongata 5-HIAA
(p = 0.008) concentrations were significantly increased, with medulla
oblongata HVA (p = 0.041) levels decreased in CIH+PREB compared
Fig. 3. CIH did not alter cardiorespiratory responses to pulmonary vagal afferent C-fibre stimulation
a) Representative traces of blood pressure, heart rate, peripheral oxygen saturation (SpO2) and raw and integrated diaphragm (Dia) electromyogram (EMG) activity during
intravenous administration of the 5-HT3 agonist, phenylbiguanide (25mg.kg1 i.v.). Group data for maximum apnoea duration (b) and tachypnoea (c) normalised to respective base-
line respiratory period in Sham+VEH, CIH+VEH, Sham+PREB and CIH+PREB rats. Absolute change in MAP (d) and heart rate (e) in response to PBG in Sham, CIH, Sham+PREB and CIH
+PREB rats. MAP, mean arterial blood pressure; CIH, chronic intermittent hypoxia; PREB, prebiotic; VEH, vehicle. Data (b-e) are expressed as box and whisker plots (median, IQR
and minimum to maximum values); n = 912. Groups (b-e) were statistically compared using two-way ANOVA, followed by Fisher’s least significant difference (LSD) post hocwhere
appropriate, or non-parametric Kruskal-Wallis test, followed by Mann-Whitney U test,where appropriate. CIH exposure had no effect on hypotension, bradycardia, apnoea or post-
apnoea induced tachypnoea (p>0.05; Fig. 3b-e). Prebiotic supplementation had a significant effect on apnoea duration (p = 0.032; Fig. 3b), with no effect on any of the other parame-
ters (p<0.05; Fig. 3c-e).
K.M. O’Connor et al. / EBioMedicine 59 (2020) 102968 11with CIH+VEH rats. CIH+PREB rats had reduced pontine L-DOPA (p =
0.038) concentrations compared with Sham+PREB rats. Sham+PREB
rats had increased pontine DOPAC (p = 0.021) as well as reduced
medulla oblongata HVA (p = 0.006) and HVA/DA (p = 0.016) concentra-
tions compared with Sham+VEH rats. Additionally, Sham+PREB rats
had elevated pontine L-DOPA (p = 0.012) concentrations comparedTable 6
Cardiovascular responses to pharmacological blockade of sympathetic activity in urethane




Propranolol (% change from baseline)
SBP 24 § 9 22 § 6 21 § 6 23§ 5 0.906 N
HR 12 § 5 18 § 13 16 § 6 19§ 11 0.092 N
Atenolol (% change from baseline)
SBP 8 § 10 9 § 5 3 § 5 7 § 3 0.025 N
HR 27 § 17 28 § 11 28 § 10 30§ 5 0.276 N
Hexamethonium (% change from baseline)
SBP 48 § 9 46 § 8 41 § 7 46§ 6 N/A D
CI
D
HR 14 § 17 15 § 18 13 § 14 12§ 11 0.743 N
SBP, systolic blood pressure; HR, heart rate; CIH, chronic intermittent hypoxia; PREB, pre
using two-way ANOVA, followed by Fisher’s least significant difference (LSD) post hoc wh
U test,where appropriate. Statistical significance for multiple comparisons was accepted a
p-values shown in bold highlight significant differences.with Sham+VEH rats. After adjusting for multiple comparisons, differ-
ences in pontine L-DOPA and medulla oblongata HVA concentrations in
Sham+PREB compared with Sham+VEH and medulla oblongata 5-HIAA
concentrations in CIH+PREB compared with Sham+PREB remained sig-
nificantly different. In summary, prebiotic administration, but not CIH,











/A    
/A    
/A 0.268 0.538 0.006 0.235
/A    
iet, p = 0.205;
H, p = 0.422;
iet*CIH, p = 0.184
   
/A    
biotic; VEH, vehicle. Data are shown as mean § SD and were statistically compared
ere appropriate, or non-parametric Kruskal-Wallis test, followed by Mann-Whitney
t p<0.05 divided by the number of comparisons made, which was four i.e. p<0.0125.
Fig. 4. Prebiotic administration alters brainstem neurochemistry
Group data for L-DOPA (a), dopamine (b), DOPAC (c) DOPAC/Dopamine (d), homovanillic acid (e), homovanillic acid/dopamine ratio (f), noradrenaline (g), serotonin (h), 5-HIAA
(i) and 5-HIAA/Serotonin ratio (j) in Sham+VEH, CIH+VEH, Sham+PREB and CIH+PREB. L-DOPA, L-3,4-dihydroxyphenylalanine; DOPAC, 3,4-dihydroxyphenylacetic acid; 5-HIAA, 5-
hydroindoleacetic acid; CIH, chronic intermittent hypoxia; PREB; prebiotic; VEH, vehicle. Data (a-j) are expressed as box and whisker plots (median, IQR and minimum to maximum
values); n = 1012. Groups were statistically compared using two-way ANOVA, followed by Fisher’s least significant difference (LSD) post hocwhere appropriate, or non-parametric
Kruskal-Wallis test, followed by Mann-Whitney U test, where appropriate. L-DOPA (p = 0.003; Fig. 4a) and DOPAC (p = 0.006; Fig. 4c) concentrations in the pontine region as well as
DOPAC/DA (Diet*CIH, p = 0.042; Fig. 4d), HVA (p = 0.001; Fig. 4e), HVA/DA (p = 0.020; Fig. 4f), 5-HT (Diet, p = 0.043; Fig. 4h) and 5-HIAA (p = 0.043; Fig. 4i) concentrations in the
medulla oblongata are different. Other monoamine, metabolites and precursors were not statistically different between groups (p>0.05; Fig. 4b, 4g, 4h, 4j). ~ p = 0.008, CIH+PREB
versus CIH+VEH; $ p = 0.006, Sham+PREB versus Sham+VEH.
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Pro-inflammatory cytokines, IL-4 (X2(3) = 8.042, p = 0.045,
Fig. 5c) and TNF-a (X2(3) = 10.784, p = 0.013, Fig. 5h) were differ-
ent between groups. Post hoc analysis adjusted for multiple com-
parisons revealed that CIH exposure had no significant effect on
IL-4 or TNF-a levels. However, TNF-a and IL-4 were decreased in
Sham+PREB compared with Sham+VEH rats. All other pro-inflam-
matory cytokines and corticosterone concentrations were not dif-
ferent between groups (Fig. 5a-b, 5d-g). In summary, CIH exposureFig. 5. Corticosterone and inflammatory mediators were equivalent between groups
Group data for corticosterone concentration (a), IFN-g (b), IL-4 (c), IL-6 (d), IL-10 (e), IL
IFN-g , interferon-g; IL-4, interleukin-4; IL-6, interleukin-6; IL-10, interleukin-10; IL-13, inte
growth-related oncogene; CIH, chronic intermittent hypoxia; PREB; prebiotic; VEH, vehicle.
mum values); n = 1112. Groups (a-h) were statistically compared using two-way ANOVA
non-parametric Kruskal-Wallis test, followed by Mann-Whitney U test, where appropriate. P
affected by prebiotic administration. $ p = 0.003, Sham+PREB versus Sham+VEH.had no effect on plasma cytokine or corticosterone concentrations.
Prebiotic administration reduced TNF-a and IL-4 concentrations
compared with VEH rats.
3.10. Caecal microbiota
3.10.1. Microbiota composition and diversity
Principal component analysis revealed that CIH exposure did not
affect b-diversity of caecal contents. Prebiotic administration shifted
b-diversity in Sham+PREB and CIH+PREB compared with Sham+VEH-13 (f), KC/GRO (g) and TNF-a (h) in Sham+VEH, CIH+VEH, Sham+PREB and CIH+PREB.
rleukin-13; TNF-a, tumour necrosis factor-a; KC/GRO, keratinocyte chemoattractant/
Data (a-h) are expressed as box and whisker plots (median, IQR and minimum to maxi-
, followed by Fisher’s least significant difference (LSD) post hoc where appropriate, or
ro-inflammatory cytokines, IL-4 (p = 0.045; Fig. 5c) and TNF-a (p = 0.013; Fig. 5h) were
Fig. 6. Prebiotic administration alters rat caecal microbiota structure
Group data for principal coordinate analysis (a) in 2-dimensional representations, Chao1 (b), Shannon (c), Simpson (d) in Sham+VEH, CIH+VEH, Sham+PREB and CIH
+PREB. CIH, chronic intermittent hypoxia; PREB; prebiotic; VEH, vehicle. Data (b-e) are expressed as box and whisker plots (median, IQR and minimum to maximum val-
ues); n = 1112. Data (b-e) were statistically compared by non-parametric Mann-Whitney U test. P-value adjusted; ~ p<0.01, CIH+PREB versus CIH+VEH; $ p <0.0001,
Sham+PREB versus Sham+VEH;.
K.M. O’Connor et al. / EBioMedicine 59 (2020) 102968 13and CIH+VEH rats, respectively (Fig. 6a, p = 0.001, PERMANOVA). CIH
exposure had no effect on indices of alpha diversity (Fig. 6b-d). Prebi-
otic treatment significantly reduced bacteria species evenness in all
statistical comparisons, indicated by decreases in Shannon and Simp-
son indices of alpha diversity (Fig. 6c-d). However, bacterial species
richness, indicated by Chao1 index was not affected by prebiotic
administration (Fig. 6b). These findings suggest changes in a select
number of bacterial species with no overall difference in bacterial
richness of the caecum.
BH adjustment for multiple comparisons at bacterial species level
did not reveal statistically significant differences between CIH+VEH
and Sham+VEH rats given the exhaustive multiple comparisons per-
formed. However, large effect sizes were evident in the relative abun-
dance of Lactobacillus species between CIH+VEH and Sham+VEH rats
(Fig. 7a-h). Similarly, no statistically significant difference was evi-
dent between Sham+PREB and CIH+PREB rats. The relative abun-
dance of multiple bacterial species were different in CIH+VEH rats
compared with CIH+PREB rats and in Sham+VEH rats compared with
Sham+PREB rats. The largest difference between these comparisons
was due to a significant increase in the beneficial bacterial speciesBifidobacterium animalis in the prebiotic groups (Supplementary
excel).
3.10.2. Gut-brain module and gut-metabolic module analysis
Using known GBMs and GMMs we evaluated gut microbial func-
tions. Our novel findings reveal that CIH exposure did not affect
GBMs and GMMs analysis of caecal microbiota. However, other
unidentified pathways might be affected. Prebiotic administration
altered the microbial potential of 10 and 31 GBMs and GMMs, respec-
tively (adjusted p<0.05; Fig. 8a,b). Several GMMs and GBMs were
enriched (positive effect size) and reduced (negative effect size) in
prebiotic treated rats compared with vehicle treated rats. Interest-
ingly, GABA degradation (p = 0.9; effect size=0.4, CIH+VEH versus
Sham+VEH; p = 0.9, effect size=0.4, CIH+PREB versus Sham+PREB; p =
0.009, effect size ~1, CIH+PREB versus CIH+VEH; p = 0.001, effect size
~1, Sham+PREB versus Sham+VEH; Fig. 8c) and butyrate synthesis I (p
= 0.9; effect size=0.4, CIH+VEH versus Sham+VEH; p = 0.9, effect
size=0.3, CIH+PREB versus Sham+PREB; p = 0.2, effect size=0.6, CIH
+PREB versus CIH+VEH; p = 0.9, effect size=0.4, Sham+PREB versus
Sham+VEH; Fig. 8d) abundance trended in diverging directions in
Fig. 7. Lactobacilli species are decreased in CIH+VEH compared with Sham+VEH
Group data for Lactobacillus amylovorous (a), Lactobacillus apis (b), Lactobacillus helveticus (c), Lactobacillus jensenii (d), Lactobacillus amyloyticus (e), Lactobacillus acetotolers (f),
Lactobacillus johnsonii (g) and Lactobacillus kefiranofaciens (h) in Sham+VEH, CIH+VEH, Sham+PREB and CIH+PREB. CIH, chronic intermittent hypoxia; PREB; prebiotic; VEH, vehicle.
Data (a-h) are expressed as box and whisker plots (median, IQR and minimum to maximum values); n = 1112. Data (b-e) were statistically compared by non-parametric Mann-
Whitney U test.
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Fig. 8. Prebiotic administration alters GBMs and GMMs
K.M. O’Connor et al. / EBioMedicine 59 (2020) 102968 15
16 K.M. O’Connor et al. / EBioMedicine 59 (2020) 102968CIH-exposed rats compared with Sham rats, depending on prebiotic
or vehicle administration.
3.11. Correlation analysis
Hierarchical All-against-all correlation analysis showed that the
relative abundance of Francisella sp. FSC1006 strongly negatively cor-
related with sigh frequency during hypercapnia in rats that did not
receive prebiotics. No other significant correlations were evident
when bacterial species were assessed against all metadata. A total of
269, 16 and 110 bacterial species correlated with mean, diastolic and
systolic blood pressure, respectively when we independently investi-
gated if blood pressure parameters correlated with bacterial species
(Supplementary Tables 911).
3.12. Faecal short-chain fatty acid concentrations
PCA analysis did not identify distinct clustering of CIH+VEH com-
pared with Sham+VEH rats. However, separation of vehicle from pre-
biotic groups was evident (Fig. 9a). Fig. 9b demonstrates this
separation is due to higher concentrations of acetic, propanoic and
hexanoic acid in prebiotic groups. Further analysis revealed that pre-
biotic supplementation significantly influenced faecal acetic (X2(3) =
22.420, p<0.0005, Fig. 9c) and propanoic (X2(3) = 11.211, p = 0.011,
Fig. 9d) concentrations. Prebiotic treatment significantly increased
faecal acetic acid in all statistical comparisons (CIH+PREB versus CIH
+VEH, p = 0.002; Sham+PREB versus Sham+VEH, p = 0.001; Fig. 9c),
propanoic acid concentrations were increased in CIH+PREB compared
with Sham+PREB rats (p = 0.009; Fig. 9d). There was no significant
difference in other SCFA concentrations (Fig. 9e-h).
4. Discussion
There is a growing evidence-based consensus that the gut micro-
biota plays a modulatory role in physiological homoeostasis. Recent
studies posit that cardiorespiratory morbidity is linked to aberrant
microbiota-gut-brain axis signalling [31, 33, 35, 38]. Investigations in
rodents reveal that exposure to CIH disturbs the gut microbiota [14,
21, 22]. Exposure to CIH elicits cardiorespiratory dysfunction [2, 7, 8,
63], predominantly considered to be mediated via CIH-induced
carotid body sensitisation [5, 6, 64], but also suggested to relate to
aberrant signalling from other sites [13, 14]. When viewed together,
these observations encourage a new line of enquiry. Dysregulated
microbiota-gut-brain axis signalling in CIH-exposed rodent models
may play a modulatory role in cardiorespiratory disturbances evident
in animal models of SDB. Manipulation of the gut microbiota via anti-
biotic administration/faecal microbiota transfer perturbs the gut
microbiota and alters cardiorespiratory control [31]. Prebiotic admin-
istration by promoting the expansion of beneficial microbes could
prove effective in the prevention of CIH-induced cardiorespiratory
dysfunctions.
We sought to explore the interplay between cardiorespiratory
physiology and the gut microbiota in a rat model of SDB, investigat-
ing if manipulation of the gut microbiota by prebiotic fibre adminis-
tration could prevent or ameliorate cardiorespiratory dysfunctions
evident in a CIH animal model. The principal novel findings of this
study are: 1) CIH-exposed rats have reduced relative abundance of
Lactobacilli species; prebiotic administration shifted the bacteriaGroup data for GBMs (a) and GMMs (b) in heatmap representation, GABA degradation (
chronic intermittent hypoxia; PREB; prebiotic; VEH, vehicle. Data (c-d) are expressed as box
wise implementation of the aldex.ttest() function was used to compare multiple groups. CIH
lated many metagenomes of the GBMs and GMMs. A positive effect size indicates an increas
rats. Benjamini-Hochberg corrected q-values,* q<0.05, ** q<0.01, *** q<0.001. GABA degr
depending on prebiotic administration. ~ p<0.01, CIH+PREB versus CIH+VEH; $$$ p< 0.001, Smicrobiota composition and diversity; 2) CIH exposure did not alter
known GBMs and GMMs; prebiotic administration modulated micro-
bial functions; 3) CIH-exposed rats developed hypertension, which
prebiotics failed to prevent; 4) CIH exposure had no effect on faecal
SCFA concentrations; acetic and propanoic acid were increased in
prebiotic groups; 5) CIH exposure increased the apnoea index during
normoxia, which was unaffected by prebiotic administration; 6)
Monoamine, monoamine precursor and metabolite concentrations
were unaffected by exposure to CIH; prebiotic administration had
modest effects on brainstem neurochemistry; 7) Cardiorespiratory
responsiveness to vagal afferent nerve stimulation was unaffected by
CIH exposure; prebiotic administration had modest effects on apnoea
duration; 8) CIH did not affect ventilation or metabolism; prebiotic
administration increased ventilatory responsiveness to hypercapnia.
Exposure to CIH elicited hypertension and a shift in autonomic
balance towards sympathetic dominance, as evident by alterations in
heart rate variability and spectral analysis parameters [65, 66]. Fur-
thermore, there was an elevated propensity for central apnoea appar-
ent in CIH-exposed rats [4, 50, 67, 68]. There is considerable evidence
supporting CIH-induced sensitisation of the carotid bodies, the prin-
cipal peripheral oxygen sensors, with persistent elevation in chemo-
afferent traffic to the NTS of the brainstem and resultant potentiation
of sympathetic nervous outflow giving rise to hypertension [9, 10, 14,
69, 70]. Carotid body ablation prevents CIH-induced hypertension
and elevations in heart rate variability indicative of cardiac auto-
nomic dysfunction [9, 10]. Nevertheless, CIH-exposed guinea-pigs,
with hypoxia-insensitive carotid bodies, have altered autonomic con-
trol of heart rate associated with modification in gut microbiota com-
position and diversity [14]. Moreover, exposure to severe CIH elicits
sympathetic over-activity and hypertension in guinea-pigs in the
absence of carotid body sensitisation [13], revealing sites beyond the
carotid bodies that can contribute to the manifestation of CIH-
induced hypertension.
Increased apnoea index, an observation commonly observed in
CIH animal models, is proposed to manifest due to disturbances in
the respiratory control network [71-74]. Carotid body plasticity and
altered chemoreflex responsiveness is also suggested to be a driver of
respiratory instability and apnoea [5, 75, 76] and may have been a
driver of apnoea in our model, although the lack of change in basal
breathing and ventilatory responses to hypoxia in our study suggest
a central origin. Numerous studies have recently linked the develop-
ment of aberrant cardiorespiratory phenotypes, particularly hyper-
tension, to perturbed gut microbiota, aberrant function profiles of gut
microbes and altered SCFA production [31, 36-38, 77-79].
In our study, whole-metagenome shotgun sequencing revealed
novel data showing that CIH+VEH hypertensive rats have modest
alterations in bacterial species of the caecum, however, gut microbial
functional alterations where not different compared with Sham+VEH
normotensive rats. Interestingly, Lactobacillus rhamnosus supplemen-
tation ameliorated CIH+HSD-induced hypertension in rats [80]. The
relative abundance of L. rhamnosus was reduced in CIH+VEH com-
pared with Sham+VEH, however this species did not pass the 0.5%
threshold. In our study, other Lactobacilli species were decreased in
CIH+VEH compared with Sham+VEH rats suggesting that CIH-
induced reductions in the relative abundance of Lactobacilli species
may have contributed to the development of cardiovascular and
autonomic dysfunction in our study, not least the development of
hypertension. However, the relative abundances of Lactobacillic) and Butyrate synthesis I (d) in Sham+VEH, CIH+VEH, Sham+PREB and CIH+PREB. CIH,
and whisker plots (median, IQR and minimum to maximum values); n = 1112. A pair-
exposure did not alter GBMs and GMMs. Prebiotic administration significantly modu-
e in prebiotic treated rats, a negative effect size indicates a decrease in prebiotic treated
adation and Butyrate synthesis I diverge in CIH-exposed compared with Sham rats,
ham+PREB versus Sham+VEH.
Fig. 9. Prebiotic administration increases faecal acetic and propanoic acid
Score plot (a) from principal component analysis (PCA) model calculated on the relative concentrations of detected SCFA and loading plot (b) from PCA model calculated on the
relative concentrations showing which variables are responsible for the pattern observed in (a). Group data for acetic acid (c), propanoic acid (d), hexanoic acid (e), butanoic acid (f),
pentanoic acid (g) and 3-methylbutanoic acid (h) in Sham+VEH, CIH+VEH, Sham+PREB and CIH+PREB. CIH, chronic intermittent hypoxia; PREB; prebiotic; VEH, vehicle. Data (c-h)
are expressed as box and whisker plots (median, IQR and minimum to maximum values); n = 1112. Groups (c-h) were statistically compared using two-way ANOVA, followed by
Fisher’s least significant difference (LSD) post hoc where appropriate, or non-parametric Kruskal-Wallis test, followed by Mann-Whitney U test, where appropriate. Acetic
(p<0.0005; Fig. 8c) and propanoic acid (p = 0.011; Fig. 8d) were increased as a result of prebiotic supplementation. All other SCFAs were not different (p>0.05 Fig. 8e-h). ~ p = 0.002,
CIH+VEH versus CIH+PREB; $ p = 0.001, Sham+PREB versus Sham+VEH.
K.M. O’Connor et al. / EBioMedicine 59 (2020) 102968 17species were not different between other respective comparisons
(Sham+VEH vs Sham+PREB; CIH+VEH vs CIH+PREB; Sham+PREB vs
CIH+PREB). Furthermore, the relative abundance of other commensal
bacteria species considered relevant to cardiometabolic health, such
as Akkeramansia muciniphila were unchanged in CIH-exposed rats[81]. If gut microbiota contribute to CIH-induced hypertension, it is
more likely that a complex interplay of bacterial species contribute to
the development of hypertension or the maintenance of normal
blood pressure per se. In our study, a large number of bacterial species
correlated with blood pressure parameters.
18 K.M. O’Connor et al. / EBioMedicine 59 (2020) 102968To our knowledge there are no studies using whole-genome shot-
gun sequencing to investigate the gut microbial functions in OSA/
hypertensive rodent models or animals treated with prebiotics. This
area of research is in its infancy. In humans, numerous modules,
essential for the host, were reduced and enriched in hypertensive
compared with normotensive patients [32, 77, 78]. In our study,
GBMs and GMMs were not altered in Sham+VEH compared with CIH
+VEH rats and Sham+PREB compared with CIH+PREB rats, revealing
that the microbial function is unaltered as a result of CIH exposure.
Many bacteria species share functional characteristics, such that
microbial communities with different taxonomic composition often
appear to be functionally similar [82]. To this end, it appears that the
functional traits of the CIH-exposed gut microbiota are not different
despite changes in Lactobacilli species. Prebiotics had significant
effects on gut microbial functions, resulting in increases and
decreases in multiple modules important to the host. For example,
increases in propionate synthesis in prebiotic groups determined by
GBMs and GMMs, coincides with elevated faecal propionate acid in
prebiotic treated rats.
Acetate-producing bacteria taxa, such as Holdemania were shown
to be decreased in hypertensive rodents [33, 36]. Intriguingly, probi-
otic or prebiotic administration prevented the progression of hyper-
tension in an OSA+HFD rat model, increasing caecal acetate and
various SCFA producing bacteria that are diminished in the hyperten-
sive rats [33]. In our study, faecal SCFA concentrations were unaf-
fected by CIH exposure, yet, CIH-exposure caused hypertension,
revealing that depletion of faecal SCFAs is not obligatory for the
development of CIH-induced hypertension. Prebiotic administration
increased faecal acetic and propionic acid concentrations but had no
beneficial effects on cardiovascular control; hypertension and
enhanced heart rate variability remained evident in CIH+PREB rats.
Prebiotic administration did not ameliorate CIH-induced hyperten-
sion revealing that elevations in faecal SCFA concentrations (or at
least increases in acetic acid and propionic acid) do not protect
against CIH-induced hypertension. Noteworthy, other metabolites
have also been linked to cardiovascular control and the development
of hypertension. These include trimethylamine-N-oxide, oxidised
low-density lipoprotein, nitric oxide, as well as metabolites of trypto-
phan, tryptophol and kynurenine [83]. Prebiotic administration
altered tryptophan degradation in both sham and CIH-exposed rats
as assessed using the GBM module, but did not ameliorate hyperten-
sion, suggesting that it does not play a significant role in the develop-
ment of cardiovascular morbidity in our animal model.
Our modest CIH paradigm did not increase plasma or brainstem
pro-inflammatory cytokines, consistent with other studies showing
no difference in systemic pro-inflammatory cytokine concentrations
following exposure to CIH [80, 84]. However, others have displayed
neuro- and systemic inflammation as a result of severe CIH exposure
[20, 84-86]. Differences are likely due to pattern, duration and inten-
sity of CIH exposure. In rodents, exposure to CIH has been shown to
increase plasma lipopolysaccharide (LPS) and elevate gut inflamma-
tion, contributing to intestinal barrier dysfunction [21, 87], a pheno-
type also evident in other hypertensive models [32, 79]. Although,
we did not examine intestinal function in our study, given that
plasma inflammatory mediators were not affected by CIH in our
model, we suggest that gut barrier integrity was maintained. Hence,
we suggest that systemic inflammation did not contribute to the
development of CIH-induced cardiorespiratory dysfunction in our
study. This does not preclude possible involvement of microbiota-
gut-brain axis signalling in the elaboration of cardiorespiratory dys-
function in other models and in OSA. Notably, faecal microbiota
transfer from donor normotensive rats to hypertensive recipient rats,
and prebiotic and probiotic administration each independently
decrease blood pressure, and prevent intestinal dysfunction and neu-
roinflammation in hypertensive models, including animal models of
OSA [33, 38, 80].Prebiotic administration increased chemoreflex control of breath-
ing in response to hypercapnia and hypoxic hypercapnia. Hypercap-
nia is primarily sensed by central chemoreceptors residing in the
brainstem. Increased ventilatory responsiveness to hypercapnia is
particularly interesting given that rats exposed to pre-natal stress
exhibit altered ventilatory responsiveness to hypoxic and hypercap-
nic chemostimulation in adulthood, which correlated with changes
in the gut microbiota [29]. Moreover, antibiotic administration and
faecal microbiota transfer were shown to perturb the gut microbiota
composition and blunt chemoreflex control of breathing [31]. The lat-
ter observation combined with findings from the present study sug-
gests that the gut microbiota may shape brainstem responsiveness to
carbon dioxide (acidosis) with implications for a range of respiratory
control disorders.
We assessed monoamines and monoamine metabolites and pre-
cursors in the pons and medulla oblongata of the brainstem that are
crucial in the neuromodulation of cardiorespiratory control. No sig-
nificant modifications in monoamine, metabolite and precursor con-
centrations were evident in the brainstem of CIH-exposed rats. There
was a trend for reduced dopamine turnover in the medulla oblongata
of Sham+PREB rats, with elevated ventilatory responses to hypercap-
nia and hypoxic hypercapnia compared with Sham+VEH rats. This
finding is particularly interesting given that rats that received antibi-
otics or faecal microbiota transfer, each resulting in perturbed gut
microbiota, display blunted ventilatory responses to hypercapnia and
exhibit increased brainstem dopamine turnover [31]. Intravenous
administration of a D1 receptor agonist increases reactivity to carbon
dioxide [88], therefore perhaps D1 receptor activation underpins ele-
vated ventilatory responses to chemostimulation in Sham+PREB rats.
Previous studies demonstrate that prebiotic administration affected
DOPAC concentrations in the brainstem and frontal cortex of mice
[89]. Yet, prebiotic administration did not alter other monoamine,
metabolites and precursors of the dopaminergic pathway in animal
models [89, 90]. CIH+PREB rats revealed significantly increased 5-
HIAA concentrations in the medulla oblongata compared with CIH
+VEH rats. Noteworthy, lesions of raphe serotonergic neurons and
transgenic rodents without 5-HT neurones display reduced respira-
tory responsiveness to hypercapnic chemostimulation [91-94]. How-
ever, serotonin turnover was not different in CIH+PREB rats
compared with CIH+VEH. It is not likely that serotonin mediated the
elevated ventilatory drive to breathe in response to hypercapnia
associated with prebiotic supplementation. Altered 5-HT receptor
levels and 5-HT concentrations have been observed in the rodent
pre-frontal cortex after prebiotic administration [89, 95]. It is unlikely
that 5-HT is implicated in the ventilatory changes described in this
study. However, decreased dopamine turnover in Sham+PREB rats
may be related to increased ventilatory responses to hypercapnia
and hypoxic hypercapnia.
The afferent vagal pathway is a pivotal signalling pathway of the
microbiota-gut-brain axis, which responds to various stimuli includ-
ing cytokines, bacterial metabolites including SCFAs, gut hormones
and neurotransmitters [96-100]. Central integration of vagal afferent
signals occurs within the NTS of the brainstem. PBG, which is a 5-HT3
receptor agonist, activates pulmonary vagal afferent C-fibres mani-
festing the pulmonary chemoreflex characterised by decreased blood
pressure, bradycardia, apnoea and post apnoea-induced tachypnoea.
Exposure to CIH did not affect the pulmonary chemoreflex, but prebi-
otic administration increased apnoea duration. Post hoc analysis
determined that there were no statistically significant differences
between groups suggesting that vagal influence over these critical
control centres was unaltered by any potential changes in micro-
biota-gut-brain signalling. Of interest, cardiorespiratory responses to
PBG were also unaffected in other models of disrupted gut microbiota
[31]. Thus, notwithstanding alterations to the gut microbiota in CIH
+VEH rats, as well as the notable changes in the gut microbiota, SCFA
concentrations, microbial functional characteristics and brainstem
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spiratory efferent responses to vagal afferent stimulation were
observed revealing intact pulmonary chemoreflex circuit function in
CIH-exposed and prebiotic supplemented animals. This does not pre-
clude however, the possibility of altered vagal signalling from the gut
in our models, which warrants attention in future studies.
5. Limitations
By design, we utilised a modest CIH paradigm sufficient to induce
hypertension and apnoea. Our rationale was to utilise the minimum
“dose” of CIH to evoke the classic aberrant cardiorespiratory pheno-
types and consider the effects of this paradigm on the gut microbiota.
Moreover we explored the potential capacity for prebiotic adminis-
tration, sufficient to modulate gut microbial function, to ameliorate
CIH-induced cardiorespiratory outcomes in this model. Our focus
was to consider the extent to which changes in the gut microbiota
were obligatory for OSA-related cardiorespiratory impairment, prin-
cipally focussed on CIH-induced hypertension. Notwithstanding our
findings, revealing no obligatory role for microbiota-gut-brain axis
signalling in the development of cardiorespiratory morbidity in our
model, the results do not preclude a potential role for the micro-
biota-gut-brain axis in OSA-related cardiorespiratory morbidity. A
more severe CIH paradigm with variations in the frequency of cycles,
intensity of hypoxia and/or duration of cumulative exposure would
likely elicit robust effects on the microbiota, with altered functional
characteristics. In this way, it is plausible to suggest that the micro-
biota-gut-brain axis could be implicated in the elaboration of cardio-
respiratory morbidity, and therefore could yet be a potential
therapeutic target. Our data point to mechanisms independent of the
gut-brain axis in the development of CIH-related morbidities, most
likely related to carotid body sensitisation, but they do not exclude
the possibility of an important contribution by the gut-brain axis in
the maintenance and progression of cardiorespiratory morbidity in
circumstances wherein CIH evokes disruption to the gut microbiota
and gut barrier permeability.
We examined only one prebiotic combination at one dose for one
period in our study. It would be of interest to investigate the effects
of different prebiotic strategies on cardiorespiratory control in CIH
models. Additionally, other microbiota interventions such as probiot-
ics or faecal microbiota transfer may prove efficacious in preventing
CIH-induced hypertension. Indeed, L. rhamnosus and normotensive
faecal matter have been shown to be beneficial in animal models of
OSA-induced hypertension [38, 80]. However, it is worth recognising
that precautions should be taken when using faecal microbiota trans-
fer and probiotic strains. For example, faecal microbiota transfer has
been shown to blunt ventilatory responses to elevated carbon diox-
ide in rats [31]. Lactobacilli probiotic species have been associated
with adverse outcomes in humans including abscesses, pneumonia
and sepsis [101]. Further work is required to investigate if different
microbiota intervention strategies have beneficial effects on cardiore-
spiratory control in CIH-exposed rats.
Whereas we assessed inflammatory cytokines in plasma as an
index of global inflammation, we did not examine intestinal perme-
ability, which is altered in severe models of CIH exposure [22, 87].
Differences in our findings compared with others may relate to differ-
ences in intestinal barrier function and integrity. As systemic inflam-
mation was not evident in CIH-exposed rats in our study, we posit
that intestinal permeability is not likely altered in our animal model,
but this remains to be determined.
We measured faecal SCFA concentrations but these do not neces-
sarily represent concentrations in plasma and target tissues, such as
the gut or brain. The functions of SCFAs depend upon activation of
transmembrane G-protein coupled receptors [102]. We did not
explore SCFA receptor expression or downstream signalling in targettissues of interest. We acknowledge that this is a limitation of our
study. In particular, regarding prebiotic strategies, our study does not
rule out the possibility that strategies that are effective in eliciting
SCFA-dependant signalling in one or more sites could yet prove bene-
ficial in protecting against CIH-induced cardiorespiratory dysfunction
in our model, as has been shown in other models.6. Conclusion
Our novel findings add to the growing understanding of the role
of the microbiota-gut-brain axis in the control of breathing and car-
diovascular function [31, 33, 80]. Herein we confirm that CIH expo-
sure leads to the development of adverse cardiorespiratory and
autonomic control, resulting in hypertension, cardiac autonomic
imbalance and elevated propensity for apnoea. We revealed for the
first time using whole-metagenome shotgun sequencing that Lacto-
bacilli species were decreased in CIH-exposed rats, but gut microbial
functional characteristics were unaltered. Faecal SCFA concentrations
were not altered by CIH exposure. Prebiotics increased faecal SCFAs
and modulated GBMs and GMMs but were not effective in preventing
CIH-induced cardiorespiratory dysfunction. Interestingly, ventilatory
responses to hypercapnic and hypoxic hypercapnic chemostimula-
tion were altered in prebiotic treated groups. Significant modulations
to the gut microbiota may shape brainstem responsiveness to acido-
sis which has implications for homoeostatic function of integrative
body systems. Our findings extend previous knowledge of the rela-
tionship between the gut microbiota and cardiorespiratory control in
OSA animal models. Our results demonstrate that in a relatively mild
model of CIH, sufficient to evoke classic cardiorespiratory dysfunc-
tion, changes in gut microbial function are not obligatory for the
development of morbidity. However, our study does not exclude the
potential for microbiota-gut-brain axis involvement in severe CIH
models and hence OSA, wherein the microbiota-gut-brain axis may
be relevant in the elaboration and maintenance of cardiorespiratory
morbidity with progressive disease.Competing interests
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